Covid-19 Vaccinated Maternal/Cord Blood Dont Have Neutralization for Omicron Variants
Topics in Antiviral Medicine
; 31(2):319, 2023.
Artículo
en Inglés
| EMBASE | ID: covidwho-2314967
ABSTRACT
Background:
Maternally derived antibodies are crucial for neonatal immunity. Understanding the binding and -cross neutralization capacity of maternal/ cord antibody responses to COVID-19 vaccination during pregnancy can inform neonatal immunity. Method(s) Here we characterized binding and neutralizing antibody profile at delivery in 24 pregnant individuals following two doses of Moderna mRNA-1273 or Pfizer BNT162b2 vaccination. We evaluated the transplacental antibody transfer by profiling maternal and umbilical cord blood. We analyzed for SARS-CoV-2 multivariant cross-neutralizing antibody levels for wildtype Wuhan, Delta, Omicron BA1, BA2, and BA4/BA5 variants by enzyme-linked immunosorbent assayResults:
Our results reveal that current vaccination induced significantly higher (p=0.003) RBD-specific binding IgG titers in cord blood compared to maternal blood for both Wuhan and Omicron BA1 strain. Interestingly, binding IgG antibody levels for the Omicron BA1 strain were significantly lower (P< 0.0001) when compared to the Wuhan strain in both maternal and cord blood. In contrast to the binding, the Omicron BA1, BA2, BA4/5 specific neutralizing antibody levels were significantly lower (P< 0.0001) compared to the Wuhan and Delta variants. It is interesting to note that the BA4/5 neutralizing capacity was not at all detected in both maternal and cord blood. Conclusion(s) Our data suggest that the initial series of COVID-19 mRNA vaccines were immunogenic in pregnant women, and vaccine-elicited binding antibodies were detectable in cord blood at significantly higher levels for Wuhan and Delta variants but not for Omicron variants. Interestingly, the vaccination did not induce neutralizing antibodies for Omicron variants. These results provide novel insight into the impact of vaccination on maternal humoral immune response and transplacental antibody transfer for SARS-CoV-2 variants and support the need for boosters as new variants emerge.
adult; clinical article; conference abstract; controlled study; coronavirus disease 2019; enzyme linked immunosorbent assay; female; human; humoral immunity; immunoglobulin blood level; maternal blood; nonhuman; obstetric delivery; passive immunization; pregnancy; pregnant woman; primary motor cortex; protein fingerprinting; SARS-CoV-2 Delta; SARS-CoV-2 Omicron; Severe acute respiratory syndrome coronavirus 2; umbilical cord blood; vaccination; broadly neutralizing antibody; elasomeran; endogenous compound; immunoglobulin G; immunoglobulin G antibody; tozinameran
Buscar en Google
Colección:
Bases de datos de organismos internacionales
Base de datos:
EMBASE
Tópicos:
Vacunas
/
Variantes
Idioma:
Inglés
Revista:
Topics in Antiviral Medicine
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS